BFRI Stock Alert: The Social Media Chatter That Has Biofrontera Booming Today

Biofrontera (NASDAQ:BFRI) stock is on the move today as traders take to Twitter (NYSE:TWTR) to discuss the latest news surrounding the company.

BFRI stock: the Biofrontera logo on its website

Source: Pavel Kapysh / Shutterstock

The big news boosting BFRI stock today seems to be Benchmark analyst Bruce Jackson initiating coverage of the stock. The analyst announced their coverage after-hours yesterday, which explains why shares are reacting to the news today.

Jackson kicks off his coverage of BFRI stock with a buy rating and price target of $11 per share. For comparison, the consensus rating and price target for the stock is a buy and $15.50 per share.

Let’s take a look at what Twitter is saying about BFRI stock today below!

BFRI Stock Twitter Talk

The extra eyes on BFRI stock come with heavier-than-normal trading for the shares. That includes some 52 million shares changing hands as of this writing. That’s a major jump over the company’s daily average trading volume of about 22.3 million shares.

Biofrontera is a dermatology company focusing on skin protection. That includes through its photodynamic therapy medication. It was founded in 1997 by Dr. Hermann Lübbert and operates out of Germany.

BFRI stock is up 49% as of Tuesday morning and is up 157.9% since the start of the year.

Investors looking for more stock market news today are in the right place!

InvestorPlace has all the latest stock market news you need to know about for Thursday! Among that is what’s happening with Cassava Sciences (NASDAQ:SAVA), Micron Technology (NASDAQ:MU), and Reliance Global (NASDAQ:RELI) shares today. You can find out more at the following link!

More Stock Market News for Tuesday

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that’s writers disclose this fact and warn readers of the risks. 

Read More:Penny Stocks — How to Profit Without Getting Scammed

Article printed from InvestorPlace Media,

©2023 InvestorPlace Media, LLC